Mableukine2-PD1

N/A

Report date: 2021/12/08 15:55:56

Base Information

Drug NameMableukine2-PD1

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionProgrammed cell death protein 1 blockersInterleukin-2 receptor agonists

TargetsProgrammed cell death protein 1Interleukin-2 receptor

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAnwita Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesAnwita Biosciences Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A